Blogs

Latest Blogs

S-Pindolol: The Fight Against Cancer Cachexia

November 13, 2025

Cancer cachexia is a silent thief. It robs patients of strength, stripping away muscle and fat, leaving them frail and exhausted.…

The Silence of the Genes: Unlocking Antisense Oligonucleotide Therapies for the Renin-Angiotensin-Aldosterone System

October 22, 2025

The field of gene therapy is rapidly evolving, with antisense oligonucleotide therapies emerging as powerful tools for modulating gene expression.…

From Signals to Systems: Olink Proteomics as a Cornerstone of Synexa’s Biomarker Strategy

October 14, 2025

We have entered a new era of modern science, where therapeutic innovation is reshaping the field of medicine.…

GMP Grade Ligand Binding and Potency Assays – Frequently Asked Questions

September 11, 2025

Good Manufacturing Practice ligand binding and potency assays are essential for ensuring the quality, safety, and regulatory compliance of biopharmaceutical…

Validating Immunity: How ELISpot Data Shaped the AELIX-003 HIV Cure Trial

July 2, 2025

We are proud to share our laboratory’s role in a landmark clinical study published in Nature Communications, titled “Safety, immunogenicity…

From Pathways to Proof: Targeted Phosphoproteomics and PTM Analysis with LC-MS/MS

June 18, 2025

Quadrupole mass spectrometry (LC-MS/MS) has long established itself as the workhorse of bioanalysis for small molecules, valued for its high…

Establishing Biosimilarity: Regulatory and Scientific Expectations

June 5, 2025

A biosimilar is defined as a biologic product, highly similar to a reference or originator, with no clinically meaningful differences…